-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Sqz-Aacs (Oncology) in Vaginal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sqz-Aacs (Oncology) in Vaginal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Sqz-Aacs (Oncology) in Vaginal CancerDrug Details:Cell therapy is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SQZ-AACs (Oncology) in Head And Neck Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SQZ-AACs (Oncology) in Head And Neck Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Sqz-Aacs (Oncology) in Head And Neck Cancer Drug Details:Cell therapy...
-
Thematic Analysis
NewDigital Twins – Thematic Intelligence
Digital Twins Thematic Report Overview Digital twins are digital representations of physical assets, systems, people, or processes. They help in detecting, preventing, predicting, and optimizing the physical environment using artificial intelligence (AI), real-time analytics, visualization, and simulation tools. Digital twins can provide short and long-term efficiency and productivity gains by dynamically integrating data and information about an asset, part, process, or system’s lifecycle. They are a data resource that can improve asset design, understand an existing asset’s condition, verify the...
-
Thematic Analysis
Cloud Computing – Thematic Intelligence
Cloud Computing Thematic Report Overview The cloud services sector competes to provide the best artificial intelligence (AI) platforms and services, partly catalyzed by the emergence of generative AI. AI is now central to the cloud services market, from developing custom chips and supporting workloads and providing the models and tools necessary to develop AI-enabled solutions. The Cloud Computing  thematic intelligence report provides an overview of the cloud computing theme. It identifies the key trends impacting the growth of the theme...
-
Thematic Analysis
Frictionless Commerce – Thematic Intelligence
Frictionless Commerce Thematic Report Overview At present, consumers demand instant gratification, and frictionless commerce aims to provide it. Frictionless commerce was pioneered by Amazon. It uses technology to identify the shopper, recognize their chosen objects, and bill them after they leave the store. The Frictionless Commerce thematic intelligence report provides an overview of the current landscape, as well as key players making a mark within it. The report provides an industry-specific analysis based on GlobalData databases and surveys, along with...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TCB-002 in Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TCB-002 in Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TCB-002 in Acute Lymphocytic Leukemia (ALL, Acute...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Utomilumab in Mantle Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Utomilumab in Mantle Cell Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Utomilumab in Mantle Cell Lymphoma Drug Details: Utomilumab (PF-05082566) is under...